Skip to main content
. Author manuscript; available in PMC: 2014 Feb 19.
Published in final edited form as: Sarcoidosis Vasc Diffuse Lung Dis. 2013 Nov 25;30(3):201–211.

Fig. 4.

Fig. 4

Reductions in immune responses against ESAT-6. Analogous to reports of declining immunoreactivity against microbial antigens following antifungal and antituberculous treatment, reductions in adaptive immune responses against ESAT-6 was noted post completion of the CLEAR regimen. Data was collected on the six subjects for whom PBMC were available.